Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 1,420.80
+22.10 (1.58%)
Feb 16, 2026, 3:30 PM IST
Dr. Lal PathLabs Revenue
Dr. Lal PathLabs had revenue of 6.60B INR in the quarter ending December 31, 2025, with 10.57% growth. This brings the company's revenue in the last twelve months to 26.63B, up 10.75% year-over-year. In the fiscal year ending March 31, 2025, Dr. Lal PathLabs had annual revenue of 24.61B with 10.54% growth.
Revenue (ttm)
26.63B
Revenue Growth
+10.75%
P/S Ratio
8.92
Revenue / Employee
5.35M
Employees
4,980
Market Cap
237.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 24.61B | 2.35B | 10.54% |
| Mar 31, 2024 | 22.27B | 2.10B | 10.40% |
| Mar 31, 2023 | 20.17B | -705.26M | -3.38% |
| Mar 31, 2022 | 20.87B | 5.06B | 32.01% |
| Mar 31, 2021 | 15.81B | 2.51B | 18.86% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| Piramal Pharma | 88.71B |
| Emcure Pharmaceuticals | 88.50B |
| Sagility | 67.37B |
| Krishna Institute of Medical Sciences | 36.27B |
Dr. Lal PathLabs News
- 13 days ago - Dr Lal PathLabs share in focus as CLSA sees ~17% upside on volume-led growth - Business Upturn
- 17 days ago - Dr. Lal PathLabs Ltd (BOM:539524) Q3 2026 Earnings Call Highlights: Steady Revenue Growth Amid ... - GuruFocus
- 17 days ago - Q3 2026 Dr. Lal PathLabs Ltd Earnings Call Transcript - GuruFocus
- 18 days ago - Earnings To Watch: Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) Reports Q3 2026 Result - GuruFocus
- 2 months ago - Dr. Lal PathLabs fixes December 19 as record date for 1:1 bonus issue - Business Upturn
- 3 months ago - Dr. Lal PathLabs Ltd (BOM:539524) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 3 months ago - Q2 2026 Dr. Lal PathLabs Ltd Earnings Call Transcript - GuruFocus
- 3 months ago - Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) Q2 2026 Earnings Report Preview: What To Expect - GuruFocus